Clinical Trial Site

Lincoln, Nebraska 68516

1 studies enrolling now · 6 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, Healthy, High Cardiovascular Risk, Hypertension, Metastatic Breast Cancer

Studies at this site

• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy Adults — Completed
• A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults — Completed
• Study of Radiolabeled ALXN2050 in Healthy Adult Males — Completed
• A Study to Assess ACH-0145228 When Administered as Immediate Release Tablet Versus Powder-In-Capsule in Healthy Adult Participants — Completed